These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20411788)

  • 1. Gene therapy for Parkinson's disease.
    Yasuhara T; Date I
    J Neural Transm Suppl; 2009; (73):301-9. PubMed ID: 20411788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future and current surgical therapies in Parkinson's disease.
    Betchen SA; Kaplitt M
    Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application.
    Yasuhara T; Date I
    Cell Transplant; 2007; 16(2):125-32. PubMed ID: 17474294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy for Parkinson's disease].
    Fraix V
    Rev Med Interne; 2004 Jul; 25(7):524-7. PubMed ID: 15219371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for Parkinson's disease.
    Mochizuki H; Mizuno Y
    J Neural Transm Suppl; 2003; (65):205-13. PubMed ID: 12946058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy in Parkinson's disease: rationale and current status.
    Feng LR; Maguire-Zeiss KA
    CNS Drugs; 2010 Mar; 24(3):177-92. PubMed ID: 20155994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
    Kupsch A; Oertel WH; Earl CD; Sautter J
    J Neural Transm Suppl; 1995; 46():193-207. PubMed ID: 8821056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral vectors in the treatment of Parkinson's disease.
    Latchman DS; Coffin RS
    Mov Disord; 2000 Jan; 15(1):9-17. PubMed ID: 10634236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to ex vivo gene therapy in the treatment of Parkinson's disease.
    Ishida A; Yasuzumi F
    Brain Dev; 2000 Sep; 22 Suppl 1():S143-7. PubMed ID: 10984676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral vectors for gene therapy in Parkinson's disease.
    Latchman DS; Coffin RS
    Rev Neurosci; 2001; 12(1):69-78. PubMed ID: 11236066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-based therapies in Parkinson's disease.
    Allen PJ; Feigin A
    Neurotherapeutics; 2014 Jan; 11(1):60-7. PubMed ID: 24129887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific rationale for the development of gene therapy strategies for Parkinson's disease.
    Björklund T; Kirik D
    Biochim Biophys Acta; 2009 Jul; 1792(7):703-13. PubMed ID: 19254760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease.
    Hernandez-Chan NG; Bannon MJ; Orozco-Barrios CE; Escobedo L; Zamudio S; De la Cruz F; Gongora-Alfaro JL; Armendáriz-Borunda J; Reyes-Corona D; Espadas-Alvarez AJ; Flores-Martínez YM; Ayala-Davila J; Hernandez-Gutierrez ME; Pavón L; García-Villegas R; Nadella R; Martinez-Fong D
    J Biomed Sci; 2015 Jul; 22(1):59. PubMed ID: 26198255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological treatments of Parkinson's disease].
    Nomoto M; Iwata S; Kaseda S
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):111-22. PubMed ID: 11233302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDNF family ligands: a potential future for Parkinson's disease therapy.
    Mickiewicz AL; Kordower JH
    CNS Neurol Disord Drug Targets; 2011 Sep; 10(6):703-11. PubMed ID: 21838676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of growth factors for the treatment of Parkinson's disease.
    Yasuda T; Mochizuki H
    Expert Rev Neurother; 2010 Jun; 10(6):915-24. PubMed ID: 20518608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gene therapy for Parkinson's disease].
    Muramatsu S
    Rinsho Shinkeigaku; 2012; 52(11):896-8. PubMed ID: 23196456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell reprogramming approaches in gene- and cell-based therapies for Parkinson's disease.
    Man JHK; Groenink L; Caiazzo M
    J Control Release; 2018 Sep; 286():114-124. PubMed ID: 30026082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for Parkinson's disease: progress and challenges.
    Chen Q; He Y; Yang K
    Curr Gene Ther; 2005 Feb; 5(1):71-80. PubMed ID: 15638712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.